1. Home
  2. Analysis

Nail discoloration and drugs of ingredients of teriparatide recombinant human (a real world drug study)


Summary:

Nail discoloration is found among people who take drugs with ingredients of teriparatide recombinant human, especially for people who are female, 60+ old , have been taking the drugs for 1 - 2 years. This phase IV clinical study is created by eHealthMe based on reports of 126,676 people who have side effects when taking drugs with ingredients of teriparatide recombinant human from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Forteo.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 16, 2026

126,676 people reported to have side effects when taking drugs with ingredients of teriparatide recombinant human.
Among them, 37 people (0.03%) have Nail discoloration

What is Nail discoloration?

Nail discoloration is found to be associated with 415 drugs and 989 conditions by eHealthMe. Check the latest studies of Nail discoloration.

Number of reports submitted per year:

Could drugs with ingredients of teriparatide recombinant human cause Nail discoloration?

Time on drugs with ingredients of teriparatide recombinant human when people have Nail discoloration *:

  • < 1 month: 25 %
  • 1 - 6 months: 25 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 50 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Nail discoloration when taking drugs with ingredients of teriparatide recombinant human *:

  • female: 94.29 %
  • male: 5.71 %

Age of people who have Nail discoloration when taking drugs with ingredients of teriparatide recombinant human *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 45.45 %
  • 60+: 54.55 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 8.11%
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 5.41%
  3. Pain: 1 person, 2.70%
  4. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 1 person, 2.70%
  5. Migraine (headache): 1 person, 2.70%
  6. Joint Pain: 1 person, 2.70%
  7. High Blood Pressure: 1 person, 2.70%
  8. High Blood Cholesterol: 1 person, 2.70%
  9. Depression: 1 person, 2.70%
  10. Anaemia (lack of blood): 1 person, 2.70%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Minocin: 3 people, 8.11%
  2. Gabapentin: 2 people, 5.41%
  3. Folic Acid: 2 people, 5.41%
  4. Tylenol: 2 people, 5.41%
  5. Fish Oil: 2 people, 5.41%
  6. Synthroid: 2 people, 5.41%
  7. Prolia: 2 people, 5.41%
  8. Prednisone: 2 people, 5.41%
  9. Enbrel: 2 people, 5.41%
  10. Zomig: 1 person, 2.70%

Other side effects people have besides Nail discoloration *:

You may use this to check any potential undetected side effects.

  1. Nail Disorder (disease of nail): 9 people, 24.32%
  2. Pain In Extremity: 7 people, 18.92%
  3. Onychoclasis (breaking of the nails): 6 people, 16.22%
  4. Muscle Spasms (muscle contraction): 5 people, 13.51%
  5. Skin Discoloration: 5 people, 13.51%
  6. Nausea (feeling of having an urge to vomit): 4 people, 10.81%
  7. Hair Loss: 4 people, 10.81%
  8. Hyperhidrosis (abnormally increased sweating): 3 people, 8.11%
  9. Rashes (redness): 3 people, 8.11%
  10. Drug Ineffective: 3 people, 8.11%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of teriparatide recombinant human, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on teriparatide recombinant human. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.